Patients with osteoporosis or brittle bones, who take drugs to strengthen bones may slow the depletion of bone. It can also be given to cancer patients who suffer symptoms such as multiple myeloma bone loss that can prevent the destruction of cells in the bone marrow. Thus was released the Telegraph.
The Telegraph over the weekend to write, researchers in England found that one drug, called zoledronic acid, may improve survival of cancer patients and prevent bone loss. The findings were published in the Lancet medical journal in Orlando, Florida.
It was found that zoledronic acid reduces the mortality rate of 16 percent. Dr. Vincent Rajkumar, Mayo Clinic in Rochester, Minnesota, said the other drugs available at lower prices have fewer side effects compared with zoledronic acid.